SIGNATURE2024-04-012024-06-30 SIGNATURE2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member SIGNATURE2024-04-012024-06-30in-bse-fin:OneOperatingExpenses02Member SIGNATURE2024-06-30 SIGNATURE2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543990 SIGNATURE NOTLISTED Signatureglobal (India) Limited Equity 2024-04-01 2025-03-31 2024-08-07 2024-08-01 INR Millions First quarter 16:30:00 18:05:00 2024-08-07 2024-08-07 Not applicable Single segment Real Estate 2024-04-01 2024-06-30 Unaudited Standalone 2215270000.00 353190000.00 2568460000.00 1903150000.00 1270000.00 0.00 231890000.00 329270000.00 46090000.00 190580000.00 2702250000.00 -133790000.00 0.00 -133790000.00 0.00 0.00 0.00 0.00 -133790000.00 0.00 0.00 0.00 0.00 -133790000.00 -6790000.00 -140580000.00 0.00 0.00 140510000.00 1 -0.95 -0.95 0.00 0.00 -0.95 -0.95 0.00 0.00 0.00 1. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), this Statement of Unaudited Statement Financial Results for the quarter ended 30 June 2024 ( Unaudited Standalone Financial Results ) of Signatureglobal (India) Limited (the Company”) has been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 07 August 2024 and have been subject to a limited review by the statutory auditors of the Company. 2. The Unaudited Standalone Financial Results, for the quarter ended 30 June 2024 have been prepared in accordance with the recognition and measurement principles of Indian Accounting Standards 34, Interim Financial Reporting ('Ind AS - 34'), prescribed under Section 133 of the Companies Act, 2013 (the Act) and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended). Note: For detailed notes please referthe pdf file of outcome of the Board Meeting. Impairment losses on financial assets 6800000.00 Other Expenses 183780000.00 Remeasurement (loss)/gain on defined benefit plans -6790000.00 -6790000.00 0.00 0.00